Telmavac Ct 40/6.25 Tablet 10

Telmavac CT 40/6.25 Tablet is utilised for:

• Management of hypertension or high blood pressure

• Use in combination with other antihypertensive agents for uncontrolled hypertension.

Administering Telmavac CT 40/6.25 Tablet properly is crucial, follow these steps:

• Swallow the tablet whole with a glass of water.

• Do not chew, break, or crush the tablet while consuming.

• If you feel the need to adjust your dose, consult with your doctor before making any changes.

Telmavac CT 40/6.25 Tablet is taken orally.

Telmavac CT 40/6.25 Tablet contains two active components:

• Telmisartan (40 mg): This component is an angiotensin II receptor blocker (ARB). What it does is selectively block the binding of a substance called angiotensin II to a specific receptor in your body called AT1. This blocking action prevents the narrowing of blood vessels and secretion of a hormone called aldosterone, which in turn leads to widened blood vessels and a decrease in blood pressure.

• Chlorthalidone (6.25 mg): Classified as a thiazide-like diuretic, chlorthalidone increases the excretion of sodium and chloride in your kidneys. This action reduces the volume of blood and consequently, the blood pressure. Additionally, it causes blood vessels to widen and decreases peripheral vascular resistance, further helping to lower blood pressure.

• Keep your Telmavac CT 40/6.25 Tablet in a dry place, away from direct sunlight.

• The ideal storage temperature is between 15-30°C.

• Ensure the medicine is always out of reach of children.

• Please remember to use this medicine before its expiry date.

• Since Telmavac CT 40/6.25 Tablet is used to manage hypertension, it would be beneficial for you to limit your salt intake. Excessive salt can raise blood pressure levels.

• Regular exercise can also help in managing high blood pressure. Try to incorporate physical activities like walking, cycling, or yoga into your daily routine. But do remember to consult your doctor before starting any new fitness programme.